Private equity firm TPG is exploring a sale of Astound that could value the owner of a U.S. network of regional cable TV and internet providers at more than US$8 billion, including debt, according to people familiar with the matter.01 Sep 2020 03:25AMREUTERS: Private equity firm TPG is exploring a sale of Astound that could value the owner of a U.S. network of regional cable TV and internet providers at more than US$8 billion, including debt, according to people familiar with the matter.
TPG, Morgan Stanley and JPMorgan declined to comment. RCN Telecom Services, a division of Astound, did not immediately respond to a request for comment.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Second US shale boom's legacy: Overpriced deals, unwanted assetsOil and gas companies plunged over US$156 billion into corporate takeovers and land deals during the second U.S. shale boom, in a massive bet that ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US pending home sales top forecasts, at highest since 2005US pending home sales rose in July by more than forecast to the highest level since 2005, signalling the housing market's sharp recovery will continue with borrowing costs to stay low for the foreseeable future. Read more at The Business Times.
Source: BusinessTimes - 🏆 15. / 51 Read more »
Nestle pays US$2 billion to secure Aimmune's allergy treatmentNestle plans to pay US$2 billion to gain full ownership of peanut allergy treatment maker Aimmune Therapeutics, as the Swiss company expands its ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Nestle to buy Aimmune Therapeutics for US$2.6 billionNestle said on Thursday it was offering US$34.50 per share for the remaining 74.4per cent in peanut allergy treatment maker Aimmune Therapeutics ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Nestle gets peanut allergy treatment with US$2 billion Aimmune buyoutNestle plans to pay US$2 billion to gain full ownership of peanut allergy treatment maker Aimmune Therapeutics, as the Swiss company expands its ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
China's new tech export controls could give Beijing a say in TikTok saleBEIJING: China's new rules around tech exports mean ByteDance's sale of TikTok's US operations could need Beijing's approval, a Chinese trade ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »